Latest Oncolytic virus Stories
Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer.
SAN DIEGO, June 17, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S.
CALGARY, June 16, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Phase 1 Study Evaluating Talimogene Laherparepvec Plus Ipilimumab Showed Tolerability at Doses Administered THOUSAND OAKS, Calif., June 2, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
CALGARY, June 2, 2014 /PRNewswire/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc.
CALGARY, May 20, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
Harvard Stem Cell Institute scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses.
CALGARY, May 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
CALGARY, April 14, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr.